S005 Hot Topics in Pediatric Dermatology
DESCRIPTION
This symposium aims to give up to date, in depth information regarding new and emerging trends in pediatric dermatology. The session will cover what is new in the management of inflammatory skin diseases in children such as acne, vitiligo and hidradenitis suppurativa. It will also delve into recent innovations in the care of patients with vascular anomalies and alopecia areata. Other hot topics addressed will include management of melanocytic nevi in children and adolescents, as well as the ethics of marketing skincare products directly to tweens and teens. The symposium will stress evolving therapeutics and best practices.
LEARNING OBJECTIVES
Analyze and discuss emerging trends impacting the care of children with inflammatory and genetic skin disease with respect to diagnosis and treatment
Recognize distinct types of vascular malformations and congenital melanocytic nevi and determine which require further monitoring and/or workup.
Develop and build on your treatment regimen for children and adolescents with acne vulgaris and hidradenitis suppurativa with up to date therapies
SCHEDULE
9:00 AM
Alopecia Areata
Brittany Craiglow, MD, FAAD
9:20 AM
Atopic Dermatitis
Alan D. Irvine, MD
9:40 AM
Acne Update
Dawn Eichenfield, PhD, MD, FAAD
10:00 AM
Tween Skin Care Craze! Market Targets!
Sheilagh M. Maguiness, MD, FAAD
10:20 AM
Question and Answers
Lawrence F Eichenfield, MD, FAAD, Brittany Craiglow, MD, FAAD, Dawn Eichenfield, PhD, MD, FAAD, Alan D. Irvine, MD, Sheilagh M. Maguiness, MD, FAAD
10:30 AM
Vitiligo Update
Khaled Ezzedine, MD, PhD, IFAAD
10:50 AM
Hidradenitis Suppurativa
Haley Naik, MD, FAAD
11:10 AM
Melanocytic Nevi
Elena B. Hawryluk, MD, PhD, FAAD
11:30 AM
Vascular Anomalies: Evolving Therapies
Beth Ann Drolet, MD, FAAD
11:50 AM
Question and Answers
Lawrence F Eichenfield, MD, FAAD, Beth Ann Drolet, MD, FAAD, Khaled Ezzedine, MD, PhD, IFAAD, Elena B. Hawryluk, MD, PhD, FAAD, Sheilagh M. Maguiness, MD, FAAD, Haley Naik, MD, FAAD
DIRECTOR
Lawrence F Eichenfield, MD, FAAD
CO-DIRECTOR
Sheilagh M. Maguiness, MD, FAAD
SPEAKERS
Brittany Craiglow, MD, FAAD
Beth Ann Drolet, MD, FAAD
Dawn Eichenfield, PhD, MD, FAAD
Khaled Ezzedine, MD, PhD, IFAAD
Elena B. Hawryluk, MD, PhD, FAAD
Alan D. Irvine, MD
Haley Naik, MD, FAAD
HANDOUTS
DISCLOSURES
Brittany Craiglow, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Speaker(Fees); BiologicsMD, Inc. – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Consultant(Grants/Research Funding); CorEvitas – Consultant (1099 relationship)(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Consultant(Fees), Speaker(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Fees); Incyte Corporation – Speaker(Honoraria); Leo Pharma – Advisory Board(Fees); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Beth Ann Drolet, MD, FAAD
Arkayli Biosciences – Founder(Stock);
Dawn Eichenfield, PhD, MD, FAAD
Amryt Pharma/ Chiesi Farmaceutici – Consultant(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, LP – Speaker(Honoraria); Incyte Corporation – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); NobelPharma – Advisory Board(Fees), Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Fees); Palvella Therapeutics – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Fees), Speaker(Honoraria);
Lawrence F Eichenfield, MD, FAAD
AbbVie – Consultant(Honoraria); Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Amryt Pharma – Consultant(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Board of Directors(Fees), Board of Directors(Stock Options); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Khaled Ezzedine, MD, PhD, IFAAD
AbbVie – Advisory Board(Fees); BMS – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Honoraria);
Elena B. Hawryluk, MD, PhD, FAAD
Apogee Therapeutics – Advisory Board(Honoraria); UpToDate, Inc – Other(Other Financial Benefit);
Alan D. Irvine, MD
AbbVie – Consultant(Honoraria); Almirall – Advisory Board(Fees); Apollo Therapeutics Ltd – Advisory Board(Fees); Galderma – Advisory Board(Fees); Leo Foundation – Independent Contractor(Fees); Leo Pharma – Advisory Board(Fees), Speaker(Fees); MoonLake Immunotherapeutics – Data Safety Monitoring Board(Fees); RAPT Therapeutics – Advisory Board(Fees); Regeneron – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Sitryx – Advisory Board(Fees); UCB – Advisory Board(Fees);
Sheilagh M. Maguiness, MD, FAAD
Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Stryke Club LLC – Founder(No Compensation Received);
Haley Naik, MD, FAAD
23andMe – Consultant(Honoraria); AbbVie – Consultant(Honoraria), Other(Grants/Research Funding); Aristea Therapeutics, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Dava Oncology – Consultant(Honoraria); Johnson and Johnson – Consultant(Honoraria); Medscape – Consultant (1099 relationship)(Fees); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Radera Biotherapeutics, Inc. – Stockholder Private Company(Stock Options); Radera, Inc. – Stockholder Private Company(Stock Options); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant (1099 relationship)(Fees);